Autopsy report · NCT01361087

Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome

“No outside recruitment of subjects from Main Atenolol VS Losartan NIH study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Sponsor type

University, hospital or other

Conditions

Marfan Syndrome

Interventions

Blood draw

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Feasibility of Home Telehealth Monitoring for Improvement in Management of Hypertension for Secondary Stroke Prevention
  “No recruitment of subjects” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.